H1 added $23 million to the $100 million Series C funding round it raised in November of 2021. The new funding came from Goldman Sachs Asset Management, Menlo Ventures, Transformation Capital, and Novartis Pharma AG; the first three also invested in the first tranche of the round.
H1 offers data aggregation services that enable patients, insurance companies, healthcare organizations, pharmaceutical, and biotech companies, to identify and connect with the most relevant healthcare professionals. Read more.
